Fennec Pharmaceuticals Stock Price History
| FENC Stock | USD 5.99 0.15 2.57% |
Below is the normalized historical share price chart for Fennec Pharmaceuticals extending back to November 12, 2004. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Fennec Pharmaceuticals stands at 5.99, as last reported on the 23rd of December, with the highest price reaching 6.00 and the lowest price hitting 5.73 during the day.
If you're considering investing in Fennec Stock, it is important to understand the factors that can impact its price. Fennec Pharmaceuticals appears to be slightly risky, given 3 months investment horizon. Fennec Pharmaceuticals secures Sharpe Ratio (or Efficiency) of 0.0883, which denotes the company had a 0.0883% return per unit of risk over the last 3 months. We have found thirty technical indicators for Fennec Pharmaceuticals, which you can use to evaluate the volatility of the firm. Please utilize Fennec Pharmaceuticals' Coefficient Of Variation of 1569.8, downside deviation of 4.11, and Mean Deviation of 3.43 to check if our risk estimates are consistent with your expectations.
At present, Fennec Pharmaceuticals' Common Stock Shares Outstanding is projected to increase significantly based on the last few years of reporting. The current year's Stock Based Compensation is expected to grow to about 5.6 M, whereas Total Stockholder Equity is projected to grow to (11 M). . The current year's Price Earnings To Growth Ratio is expected to grow to 0.53, whereas Price To Sales Ratio is forecasted to decline to 13.33. Fennec Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 5th of June 2001 | 200 Day MA 6.7079 | 50 Day MA 5.0846 | Beta 0.267 |
Fennec |
Sharpe Ratio = 0.0883
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | FENC | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 4.58 actual daily | 40 60% of assets are more volatile |
Expected Return
| 0.4 actual daily | 7 93% of assets have higher returns |
Risk-Adjusted Return
| 0.09 actual daily | 6 94% of assets perform better |
Based on monthly moving average Fennec Pharmaceuticals is performing at about 6% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Fennec Pharmaceuticals by adding it to a well-diversified portfolio.
Price Book 57.9258 | Enterprise Value Ebitda 51.691 | Price Sales 3.3298 | Shares Float 14.9 M | Wall Street Target Price 13.6 |
Fennec Pharmaceuticals Stock Price History Chart
There are several ways to analyze Fennec Stock price data. The simplest method is using a basic Fennec candlestick price chart, which shows Fennec Pharmaceuticals price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | December 2, 2024 | 6.24 |
| Lowest Price | November 15, 2024 | 3.99 |
Fennec Pharmaceuticals December 23, 2024 Stock Price Synopsis
Various analyses of Fennec Pharmaceuticals' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Fennec Stock. It can be used to describe the percentage change in the price of Fennec Pharmaceuticals from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Fennec Stock.| Fennec Pharmaceuticals Price Action Indicator | 0.20 | |
| Fennec Pharmaceuticals Price Rate Of Daily Change | 1.03 | |
| Fennec Pharmaceuticals Price Daily Balance Of Power | 0.56 |
Fennec Pharmaceuticals December 23, 2024 Stock Price Analysis
Fennec Stock Price History Data
The price series of Fennec Pharmaceuticals for the period between Tue, Sep 24, 2024 and Mon, Dec 23, 2024 has a statistical range of 2.25 with a coefficient of variation of 13.93. Under current investment horizon, the daily prices are spread out with arithmetic mean of 5.02. The median price for the last 90 days is 4.73. The company completed 1:3 stock split on 5th of September 2014.| Open | High | Low | Close | Volume | ||
12/23/2024 | 5.84 | 6.00 | 5.73 | 5.99 | ||
12/23/2024 | 5.84 | 6.00 | 5.73 | 5.99 | ||
| 12/20/2024 | 5.73 | 6.00 | 5.73 | 5.99 | 172,932 | |
| 12/19/2024 | 5.69 | 5.96 | 5.51 | 5.84 | 77,409 | |
| 12/18/2024 | 6.05 | 6.14 | 5.59 | 5.66 | 104,169 | |
| 12/17/2024 | 5.86 | 6.17 | 5.84 | 6.07 | 80,629 | |
| 12/16/2024 | 6.06 | 6.16 | 5.95 | 5.95 | 71,359 | |
| 12/13/2024 | 6.10 | 6.16 | 5.77 | 6.05 | 54,796 | |
| 12/12/2024 | 6.11 | 6.19 | 5.92 | 6.11 | 50,974 | |
| 12/11/2024 | 6.18 | 6.20 | 6.05 | 6.14 | 48,464 | |
| 12/10/2024 | 6.08 | 6.20 | 6.02 | 6.14 | 65,759 | |
| 12/09/2024 | 6.17 | 6.33 | 5.95 | 6.06 | 104,447 | |
| 12/06/2024 | 5.73 | 6.35 | 5.73 | 6.17 | 164,881 | |
| 12/05/2024 | 6.04 | 6.08 | 5.56 | 5.72 | 147,769 | |
| 12/04/2024 | 6.23 | 6.43 | 5.79 | 6.07 | 237,960 | |
| 12/03/2024 | 6.13 | 6.32 | 5.92 | 6.23 | 314,932 | |
| 12/02/2024 | 5.97 | 6.46 | 5.94 | 6.24 | 320,354 | |
| 11/29/2024 | 6.01 | 6.11 | 5.80 | 6.06 | 147,207 | |
| 11/27/2024 | 6.01 | 6.55 | 6.00 | 6.01 | 307,373 | |
| 11/26/2024 | 5.50 | 6.27 | 5.47 | 6.04 | 280,159 | |
| 11/25/2024 | 5.31 | 5.70 | 5.13 | 5.66 | 185,636 | |
| 11/22/2024 | 4.68 | 5.55 | 4.68 | 5.32 | 371,880 | |
| 11/21/2024 | 4.68 | 5.19 | 4.60 | 4.72 | 212,672 | |
| 11/20/2024 | 4.25 | 4.79 | 4.21 | 4.64 | 190,813 | |
| 11/19/2024 | 4.01 | 4.30 | 4.00 | 4.28 | 143,604 | |
| 11/18/2024 | 4.04 | 4.11 | 3.96 | 4.04 | 58,735 | |
| 11/15/2024 | 4.42 | 4.42 | 3.96 | 3.99 | 128,132 | |
| 11/14/2024 | 4.49 | 4.54 | 4.30 | 4.40 | 191,236 | |
| 11/13/2024 | 4.26 | 4.57 | 4.26 | 4.48 | 219,584 | |
| 11/12/2024 | 4.24 | 4.30 | 4.14 | 4.23 | 97,618 | |
| 11/11/2024 | 4.37 | 4.40 | 3.99 | 4.26 | 118,723 | |
| 11/08/2024 | 4.31 | 4.35 | 4.22 | 4.29 | 94,304 | |
| 11/07/2024 | 4.69 | 4.69 | 4.21 | 4.36 | 272,556 | |
| 11/06/2024 | 5.04 | 5.04 | 4.86 | 4.95 | 133,450 | |
| 11/05/2024 | 4.62 | 5.00 | 4.62 | 4.80 | 84,502 | |
| 11/04/2024 | 4.31 | 4.66 | 4.30 | 4.65 | 91,180 | |
| 11/01/2024 | 4.43 | 4.44 | 4.26 | 4.34 | 54,317 | |
| 10/31/2024 | 4.46 | 4.69 | 4.33 | 4.36 | 53,151 | |
| 10/30/2024 | 4.78 | 4.82 | 4.43 | 4.47 | 107,110 | |
| 10/29/2024 | 4.77 | 4.99 | 4.70 | 4.79 | 159,974 | |
| 10/28/2024 | 4.38 | 4.74 | 4.32 | 4.73 | 144,144 | |
| 10/25/2024 | 4.63 | 4.70 | 4.22 | 4.24 | 161,142 | |
| 10/24/2024 | 4.48 | 4.60 | 4.44 | 4.58 | 41,127 | |
| 10/23/2024 | 4.55 | 4.55 | 4.39 | 4.46 | 63,335 | |
| 10/22/2024 | 4.66 | 4.75 | 4.52 | 4.54 | 43,272 | |
| 10/21/2024 | 4.62 | 4.68 | 4.60 | 4.66 | 61,259 | |
| 10/18/2024 | 4.66 | 4.75 | 4.54 | 4.54 | 40,093 | |
| 10/17/2024 | 4.72 | 4.86 | 4.57 | 4.65 | 42,852 | |
| 10/16/2024 | 4.72 | 4.86 | 4.58 | 4.65 | 100,959 | |
| 10/15/2024 | 4.54 | 4.76 | 4.54 | 4.65 | 42,104 | |
| 10/14/2024 | 4.37 | 4.60 | 4.35 | 4.54 | 39,084 | |
| 10/11/2024 | 4.17 | 4.46 | 4.17 | 4.42 | 63,301 | |
| 10/10/2024 | 4.23 | 4.23 | 4.09 | 4.19 | 57,370 | |
| 10/09/2024 | 4.53 | 4.54 | 4.23 | 4.26 | 58,865 | |
| 10/08/2024 | 4.53 | 4.61 | 4.50 | 4.51 | 57,331 | |
| 10/07/2024 | 4.65 | 4.67 | 4.53 | 4.57 | 93,014 | |
| 10/04/2024 | 4.58 | 4.71 | 4.55 | 4.62 | 64,556 | |
| 10/03/2024 | 4.57 | 4.62 | 4.50 | 4.52 | 68,895 | |
| 10/02/2024 | 4.75 | 4.77 | 4.58 | 4.62 | 90,440 | |
| 10/01/2024 | 4.94 | 4.99 | 4.76 | 4.82 | 68,126 | |
| 09/30/2024 | 5.23 | 5.23 | 4.87 | 5.00 | 92,563 |
About Fennec Pharmaceuticals Stock history
Fennec Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Fennec is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Fennec Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Fennec Pharmaceuticals stock prices may prove useful in developing a viable investing in Fennec Pharmaceuticals
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 26.6 M | 27.9 M | |
| Net Loss | -21.3 M | -20.3 M |
Fennec Pharmaceuticals Quarterly Net Working Capital |
|
Fennec Pharmaceuticals Stock Technical Analysis
Fennec Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Commodity Directory Now
Commodity DirectoryFind actively traded commodities issued by global exchanges |
| All Next | Launch Module |
Fennec Pharmaceuticals Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Fennec Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Fennec Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Fennec to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0587 | |||
| Jensen Alpha | 0.2357 | |||
| Total Risk Alpha | 0.1524 | |||
| Sortino Ratio | 0.0627 | |||
| Treynor Ratio | 0.1411 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Fennec Stock analysis
When running Fennec Pharmaceuticals' price analysis, check to measure Fennec Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Fennec Pharmaceuticals is operating at the current time. Most of Fennec Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Fennec Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Fennec Pharmaceuticals' price. Additionally, you may evaluate how the addition of Fennec Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges |